Press Releases

Results found (115)
May 25, 2015
A New Drug on Market! Santen announces Approval of Ikervis for EU Marketing...

Santen Pharmaceutical Co., Ltd. today announced it received approval of the Marketing Authorization Application (MAA) for Ikervis from the European Commission. Ikervis is approved for treatment of severe keratitis in adult patients with dry eye...

April 28, 2015
Yissum Introduces Novel Method for Increasing Shelf Life of Leafy Greens

The invention to be presented at Agritech Israel 2015

March 23, 2015
ISA Scientific, Yissum, Hadasit and the Kennedy Trust for Rheumatology...

The licensed intellectual property is the result of many years of research and collaboration between renowned cannabinoid scientists, Raphael Mechoulam, Professor of medicinal chemistry, and Ruth Gallily, Professor of immunology, both from the...

January 26, 2015
Yissum and Phytotech Medical to Collaborate on Novel Delivery System for...

Phytotech Medical went public on the Australian Securities Exchange raising AUS$5.9 million dollars 

January 25, 2015
Yissum Start Up Melodea’s Chairman of the Board, Mr. Tord Gustafsson, ...

Prize awarded for contribution to collaboration between Melodea and Holmen

December 8, 2014
Integra Holdings Closes $3 Million Investment from Guangxi Wuzhou...

Integra Holdings, the biotechnology holdings company of Yissum, the technology transfer company of the Hebrew University of Jerusalem, announced today that it has received US $3 million investment from Guangxi Wuzhou Pharmaceutical Group Co.,...

October 6, 2014
Lockheed Martin and Yissum Sign Long Term Research Collaboration Agreement

Yaacov Michlin, CEO of Yissum, said at the signing ceremony: “The framework agreement we signed today sets the ground for a wide range of potential areas of research collaboration between the two parties”. 

September 17, 2014
Avraham Pharmaceuticals Raises $4.5 Million in Additional Investment Led by...

The capital is intended for the on-going Phase 2b clinical trial of ladostigil, a novel molecule for treatment of mild cognitive impairment; next interim analysis is expected in Q3 2015; final results expected in Q3 2016 

July 24, 2014
Atox Bio Closes $23 Million Investment

Funds will be used to advance development of AB103, a novel therapy for the treatment of necrotizing soft tissue infections 

April 27, 2014
Qlight Nanotech Wins Best Nanotechnology Company of the Year Award at...

Avi Hasson, Chief Scientist of Israel’s Ministry of Economy, said at the award ceremony: ”Qlight Nanotech encompasses a winning combination of outstanding technology originating from the Hebrew University together with a leading international...

February 10, 2014
Yissum Introduces a Novel Method to Develop Next-Generation Batteries

Novel sodium-ion battery is an environmentally friendly, economic and efficient solution for a variety of applications including electric vehicles and stationary storage for renewable energies

January 7, 2014
Yissum introduces Low-Cost Copper Conducting Nano-Inks

Yissum presents new oxidation-resistant copper nano-inks with a low sintering temperature (lower than 150oC), which enables the printing of low-cost conductive patterns on heat sensitive plastic substrates. Due to these traits, the new inks,...